Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies
Authors:
- 30 September 2024
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1879 (6) , 189192
Abstract
No abstract availableKeywords
This publication has 146 references indexed in Scilit:
- Classification of high‐grade cervical intraepithelial neoplasia by p16ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for managementInternational Journal of Cancer, 2021
- DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese populationInternational Journal of Cancer, 2020
- Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination statusInternational Journal of Cancer, 2019
- Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A reviewInternational Journal of Cancer, 2019
- Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trialCancer Medicine, 2019
- Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodiesCancer Medicine, 2019
- MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosisHead & Neck, 2019
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related CancerJAMA Oncology, 2019
- A phase 1/2a study to test the safety and immunogenicity of a p16INK4a peptide vaccine in patients with advanced human papillomavirus‐associated cancersCancer, 2016
- Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central ChinaInternational Journal of Cancer, 2000